Previous studies have shown that pressure overload causes copper (Cu) decrease in the heart in association with an inhibition of myocardial angiogenesis and of transition from cardiac hypertrophy to heart failure in a mouse model (Jiang et al., 2007) . Dietary supplementation with physiologically relevant levels of Cu replenishes cardiac Cu and reverses hypertrophic cardiomyopathy in the presence of pressure overload induced by ascending aortic constriction in the mouse model (Jiang et al., 2007) . Further studies have shown that dietary Cu supplementation increases myocardial vascular endothelial growth factor (VEGF) levels along with an enhanced angiogenesis. Importantly, systemic administration of anti-VEGF antibody blunts Cu regression of hypertrophic cardiomyopathy (Jiang et al., 2007) . It has also been shown that dietary Cu restriction causes suppression of VEGF expression in the heart and Cu replenishment recovers myocardial VEGF expression (Elsherif et al., 2004) . In addition, Cu stimulates VEGF expression in cultured human keratinocytes, and enhances angiogenesis and promotes wound healing (Sen et al., 2002) .
In an attempt to understand molecular mechanisms by which Cu stimulates VEGF expression, we have studied the role of transcription factor, hypoxia-inducible factor 1 (HIF-1), in regulation of Cu-mediated VEGF expression. Cu chelation suppresses the transcription activity of HIF-1 and gene silencing of α subunit of HIF-1 (HIF-1α ) blocks Cu stimulation of VEGF expression (Jiang et al., 2007) . Other studies have shown that excess Cu stabilizes HIF-1α and stimulates VEGF expression under both normoxic and hypoxic conditions (Martin et al., 2005) .
However, it is important to know how Cu regulates HIF-1 transcription activity.
HIF-1 is composed of HIF-1α and HIF-1β (Wang et al., 1995) . The synthesis and accumulation of HIF-1α is a rate-limiting step for activation of HIF-1 (Huang et al., 1998; Wang and Semenza, 1993b) .The expression level of HIF-1α is undetectable in most cell types under normoxic conditions due to its degradation by the ubiquitin-proteasome pathway, which is This article has not been copyedited and formatted. The final version may differ from this version. 5 mediated by proline hydroxylation of HIF-1α catalyzed by three HIF prolyl hydroxylases (PHDs) (Huang et al., 1998; Jaakkola et al., 2001; Ivan et al., 2001 ). The hydroxylated HIF-1α is recognized by a von Hippel-Lindau protein (pVHL), which is a constitute of an ubiquitin ligase complex, targeting HIF-1α subunit for degradation by proteasome in cytosol (Maxwell et al., 1999; Masson et al., 2001; Ohh et al., 2000; Tanimoto et al., 2000) . Under hypoxic conditions, HIF-1α escapes from the degradation pathway, accumulates, and translocates into nucleus, where it dimerizes with HIF-1β and interacts with cofactors to assemble the HIF-1 transcriptional complex. Some transition metals such as cobalt and nickel enhance HIF-1 transcription activity by stabilizing HIF-1α protein (Hirsila et al., 2005; Ke et al., 2005; Maxwell and Salnikow, 2004; Yuan et al., 2003) . In the nucleus, HIF-1α is hydroxylated on its C-terminal asparagine by another dioxygenase, factor inhibiting HIF-1 (FIH-1) . FIH-1 prevents the interaction between HIF-1α and its cofactors, such as p300, and inhibits the transcription activity of HIF-1 (Lando et al., 2002a; Lando et al., 2002b; McNeill et al., 2002; Freedman et al., 2002; Dames et al., 2002) . FIH-1 is an iron dependent enzyme. Therefore, iron chelation enhances HIF-1 transcription activity (Wang and Semenza, 1993a) .
Cu is capable of stabilizing HIF-1α by a mechanism involving the inhibition of prolyl hydroxylases (Martin et al., 2005; van Heerden et al., 2004) . However, this action of Cu would be as the same as other transition metals such as cobalt and nickel, which are not essential for HIF-1 activation, but enhance HIF-1 activity when the cells are exposed to excess amount of these transition metals (Hirsila et al., 2005; Ke et al., 2005; Maxwell and Salnikow, 2004; Yuan et al., 2003) . The critical question that we are addressing is whether or not Cu is essential for HIF-1 transcription activity.
Our previous studies have suggested that Cu is required for HIF-1 transcription activity. Cu
This article has not been copyedited and formatted. The final version may differ from this version. (Jiang et al., 2007) . In addition, we have found that this Cu action depends on a Cu chaperone for superoxide dismutase 1 (CCS) and CCS gene silencing blocks IGF-1-induced HIF-1 HRE binding and VEGF expression, mimicking the effect of Cu chelation. Furthermore, CCS directly interacts with HIF-1α, as revealed by an immunoprecipitation assay (Jiang et al., 2007) .
There are multiple sites that potentially require Cu for activation of HIF-1, including HIF-1α synthesis, stabilization, translocation from cytosol to nucleus, binding to the HRE sequence of target genes, and HIF-1 transcriptional complex formation. In the present study, we report that Cu is required for HIF-1 binding to the HRE sequence of target genes, and for the HIF-1 transcriptional complex formation in a HepG2 human hepatoma cell line.
MATERIAL AND METHODS
Cell Culture and Treatments. Human hepatoma cell line HepG2 was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 μ g/ml). Cells were routinely cultured in 95% air and 5% CO 2 at 37 ºC. Hypoxic conditions were introduced by incubating cells in a tightly sealed chamber maintained at 1% O 2, 5% CO 2 and balanced with N 2 at 37 ºC. For treatment with reagents, cells were seeded in culture dishes and grown overnight. Thereafter, tetraethylenepentamine (TEPA) or CuSO 4 was added to the cultures, followed by further incubation for the time periods as indicated in each experiment. In some experiments, deferoxamine (DFO) was added at 16 h prior to cell harvesting to induce HIF-1α accumulation.
This article has not been copyedited and formatted. The final version may differ from this version. Western Blotting. Whole cell lysates were prepared as previously described (Jaakkola et al., 2001) . Appropriate amount of protein in total cell lysates were resolved in a SDS-PAGE gel and transferred onto a polyvinylidene difluoride membrane (Whatman, Sanford, ME). Membranes were blocked for 1 h in TBST (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20)
containing 5% non-fat dry milk and incubated overnight at 4 ºC with the following primary antibodies diluted in blocking buffer: HIF-1α (BD Biosciences, San Jose, CA); p300, FIH-1 and CCS (Santa Cruz Biotech, Santa Cruz, CA), and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) (StressGen, Victoria, Canada). After washing with TBST, the membranes were incubated with a horseradish peroxidase-linked anti-mouse or -rabbit IgG antibody (GE Health Carr, Piscataway, NJ) for 1 h at room temperature. Proteins were visualized using an ECL system (GE Health Care).
Immunoprecipitation.
Immunoprecipitation was performed using anti-HIF-1α or anti-p300 (BD Biosciences) antibodies as described previously (Feng et al., 2005) . The immunopreciptates were subjected to Western blotting analysis as described above. Electrophoretic Mobility Shift Assay. Double-stranded oligonucleotides containing the HIF-1 binding sequence from erythropoietin (EPO) HRE (5′-TCT GTA CGT CAC ACT CAC CTC-3′) (Santa Cruz Biotechnology), were end-labeled with [γ-32 P]ATP (GE Health Care) using T4-polynucleotide kinase (Promega). Unincorporated nucleotide was removed by gel-filtration using a Nick column (GE Health Care). The γ-32 P-labeled HRE probe was incubated with 5-10 μg of nuclear extract and 1 μg of poly (dI-dC)·(dI-dC) (GE Health Care) in a buffer containing 10 mM
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Tris-HCl, pH 7.8, 20 mM KCl, 1 mM EDTA, 5 mM DTT, 1 mM MgCl2, and 5% glycerol overnight at 4 °C in a total volume of 20 μl. For competition assay, a 200-fold molar excess of unlabeled HRE was added to the reaction prior to addition of labelled probe. For supershift assay, 2 μl of mouse monoclonal antibody against HIF-1α (BD Biosciences) was added to the reaction 2 h before electrophoresis. Electrophoresis was performed using 5% nondenaturing polyacrylamide gel at 200 V in 0.5 x Tris-buffered EDTA for 2 h at 4 °C. The gels were dried and subjected to autoradiography for visualization.
Immunocytochemistry. HepG2 cells grown on a chamber slide were incubated under normoxia or hypoxia with or without additional treatments. After incubation, media were removed, and cells were fixed with 4% paraformaldehyde. The fixed cells were washed three times with PBS plus 3% bovine serum albumin, and incubated at 4°C overnight with rabbit polyclonal anti-HIF-1 antibody (BD Biosciences). Then the cells were washed three times with PBS plus 3% bovine serum albumin, and incubated with FITC-conjugated goat anti-rabbit IgG antibody (Sigma) for 1 h. Reaction omitting the primary antibody served as a negative control.
Statistical Analysis. Data were evaluated using Student's t test. p < 0.05 were considered to be significant.
This article has not been copyedited and formatted. The final version may differ from this version. 1 5 1 6 The effect of Cu deprivation on HIF-1 transcription activity was evaluated by two different assays. The first, hypoxia-induced VEGF production in cultured HepG2 cells was determined, and the second, a HIF-1-specific reporter assay was performed. In the first experiment, the presence of 50 μM CuSO 4 in cultures enhanced hypoxia-induced VEGF production, but the presence of 50 μM TEPA suppressed the production. To confirm that the TEPA-suppressed VEGF production results from Cu deprivation, varying concentrations of CuSO 4 were added to the TEPA-treated cultures and a Cu concentration-dependent recovery of TEPA suppression of VEGF production was observed (Fig. 1B) , indicating a selective effect of Cu chelation by TEPA.
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RESULTS
Cu Deprivation Suppresses
We next determined the effect of Cu deprivation by TEPA on HIF-1 transcription activity using a luciferase reporter assay. The HepG2 cells were transfected with a reporter plasmid containing 6X HIF-1 binding site fused with a luciferase gene (Wanner et al., 2000) . As expected, This article has not been copyedited and formatted. The final version may differ from this version. 1 5 1 6 11 the luciferase reporter gene was activated by hypoxia and TEPA treatment significantly reduced the luciferase activity. This effect of TEPA on luciferase activity was also relieved by addition of excess Cu in a Cu concentration-dependent manner (Fig. 1C) , further demonstrating the selective effect of Cu deprivation on HIF-1 transcription activity.
To further verify the effect of Cu on HIF-1 transcription activity, we determined the effect of CCS gene silencing on HIF-1-specific HRE binding activity. We have shown previously that CCS is required for Cu activation of HIF-1 (Jiang et al., 2007) . Therefore, CCS gene silencing should block hypoxia-induced activation of HIF-1, but addition of excess Cu should not overcome this effect because the action of Cu is mediated by CCS. The data presented in Fig. 1D show that a siRNA targeting CCS effectively blocked CCS production in these cells and suppressed hypoxia-induced activation of HIF-1. Addition of excess Cu did not relieve the inhibitory effect of CCS-silencing on HIF-1 activation.
Cu Deprivation Affects neither Production nor Stability of HIF-1α .
To define the action site at which Cu is required for activation of HIF-1 transcription activity, we examined whether or not Cu chelation by TEPA affects HIF-1α protein expression or stability. Under normoxic conditions, HIF-1α protein undergoes a degradation process mediated by hydroxylation of the proline residues 402 and 564 of HIF-1α by PHDs. HepG2 cells were treated with or without 100
μM TEPA under normoxic conditions for 24 h and subsequently cultured for 5 h under hypoxic conditions (1% O 2 ). Hypoxia-induced HIF-1α accumulation was detectable 5 min and reached a peak level 5 h after hypoxia (data not shown). After hypoxic treatment for 5 h, the cells were exposed to normoxic conditions for varying periods of time. There were no differences between the control and TEPA-treated cultures in hypoxia-induced HIF-1α production. Upon re-oxygenation, the HIF-1α protein was rapidly decreased in a time-dependent manner and This article has not been copyedited and formatted. The final version may differ from this version. Cu Deprivation Decreases HIF-1 Binding to the HRE. Since Cu deprivation did not change expression or stability of HIF-1α, we continued our effort to further define possible action site for Cu in activation of HIF-1. We examined the DNA-binding activity of HIF-1 using nuclear extracts from TEPA-treated HepG2 cells by an electrophoretic mobility shift assay (EMSA). The result presented in Fig. 3A shows that hypoxia increased the binding of HIF-1 to HRE (lane 2).
The treatment with TEPA decreased the binding intensity (Fig. 3A, lane 6) . To confirm the specificity of HIF-1 binding to the DNA sequence, a competition assay using 200-fold unlabeled HRE and a supershift assay using a monoclonal anti-HIF-1α antibody were performed. Unlabeled HRE competed off the binding of the labeled HRE to HIF-1 (Fig. 3A, lane 3) , and the antibody shifted the DNA-protein complex to a higher molecular mass band (Fig. 3A, lane 4&5) , indicating the specific binding of HIF-1 to the HRE (Fig. 3A) . Addition of Cu to TEPA-treated cells relieved the inhibition of HRE binding by TEPA, as shown in Fig. 3C .
This article has not been copyedited and formatted. The final version may differ from this version. is essential for HIF-1 transcription activity. We examined whether or not Cu deprivation by TEPA affects the interaction between HIF-1 and p300. We used an anti-HIF-1α antibody to perform an immunoprecipitation assay. Under hypoxic condition, p300 was co-immunoprecipitated with anti-HIF-1α antibody (Fig. 4A) . However, the amount of p300 that was precipitated by the anti-HIF-1α antibody was dramatically decreased under the treatment with TEPA (Fig. 4A) .
Addition of CuSO 4 to the TEPA-treated cells elevated the amount of p300 protein precipitated by anti-HIF-1α antibody (Fig. 4A) . A retro-immunoprecipitation was also performed using anti-p300
antibody to confirm the HIF-1α/p300 interaction. As shown in Fig. 4B , TEPA treatment decreased the amount of HIF-1α protein precipitated by anti-p300 antibody and addition of CuSO 4 relieved this inhibition.
Under normoxic conditions, FIH-1 hydroxylates Asn803 residue in HIF-1α and therefore inhibits the binding of HIF-1α to p300. However, we found that Cu deprivation did not affect the level of FIH-1 (Fig. 5A ). We then determined if Cu inhibits the activity of FIH-1. If Cu inhibits FIH-1 activity, TEPA should relieve this inhibition leading to recovery of FIH-1 activity and enhance the inhibition of HIF-1α binding to p300 along with a suppression of HIF-1 transcription activity. In this context, if FIH-1 activity is inhibited by a different mechanism, Cu deprivation should not suppress the HIF-1 transcription activity. To test this hypothesis, we used a siRNA targeting FIH-1 to delete FIH-1 in HepG2 cells ( inhibition cannot be recovered by Cu deprivation. We used an iron chelator, DFO, which has been shown to induce HIF-1 activation through inhibition of FIH-1 (Hirsila et al., 2005) . The treatment with DFO increased HIF-1 transcription activity in HepG2 cells, as determined by VEGF expression (Fig. 6A ) and luciferase reporter assay (Fig. 6B) . Pretreatment with TEPA did not affect DFO-induced VEGF expression or luciferase reporter activation (Fig. 6 ).
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DISCUSSION
In the present study, we report that Cu deprivation suppresses hypoxia-induced activation of HIF-1, thus inhibits the expression of genes such as VEGF controlled by this transcription factor.
We have presented several pieces of evidence that demonstrates Cu is required for HIF-1 activation. In the presence of Cu chelator TEPA, the expression of VEGF and the luciferase reporter activity were suppressed under hypoxic conditions. This suppression was relieved by Hypoxia is a major regulatory mechanism of HIF-1 activity. Hypoxia stabilizes HIF-1α protein, but has no effect on HIF-1α transcription, which has been shown by unchanged HIF-1α mRNA levels under hypoxic conditions (Wenger et al., 1997) . HIF-1α is also regulated by an mTOR-dependent pathway (Hudson et al., 2002) , which enhances HIF-1α protein expression (Treins et al., 2002; Phillips et al., 2005; Laughner et al., 2001 ). However, Cu deprivation affected neither synthesis nor stability of HIF-1α, indicating that Cu is required at different steps of HIF-1 activation.
The present study provides important insights into the mechanism of action of Cu in the process of HIF-1 activation. First, Cu may be required for HIF-1 binding to HRE in the target genes. In previous studies, we have observed that Cu deprivation decreases the binding of HIF-1 to HRE in cultured cells in response to IGF-1 stimulation as determined by an ELISA assay, but the total level of HIF-1α in cells was not reduced by Cu deprivation (Jiang et al., 2007) . In the present study, we observed that under hypoxic conditions, Cu deprivation also decreased the binding of HIF-1 to HRE, but we used a different assay, EMSA, to determine the binding. Therefore, these complementary results obtained from different cells under different experimental conditions confirm the inhibitory effect of Cu deprivation on the binding of HIF-1 to HRE. It appears that this process is Cu chaperone CCS-dependent. It has been shown that CCS is present in the nucleus (Casareno et al., 1998) and we have also observed the appearance of CCS in the nucleus by an immunocytochemical procedure (data not shown). While CCS may be important for Cu transport into the nucleus, it is apparently required for Cu interaction with HIF-1α because CCS is co-immunoprecipitated with HIF-1α (Jiang et al., 2007) Although the binding of HIF-1 to HRE is important, the initiation of the transcription of target genes requires a transcriptional complex (Kallio et al., 1998; Roth et al., 2004) . This complex includes several proteins and among these proteins is a p300 (Forsythe et al., 1996; Kallio et al., 1998; Arany et al., 1996; Carrero et al., 2000; Gray et al., 2005) . In this process, a critical regulatory factor is FIH-1, which causes hydroxylation of the Asn803 of HIF-1α to inhibit the recruitment of cofactors including p300 to HIF-1 transcriptional complex. It appears that this is a process involving the action of Cu, as indicated by the result that Cu deprivation reduced the binding of HIF-1 to p300. This result suggests that either Cu is required for the binding of HIF-1 to p300 or Cu inhibits FIH-1 activity, relieving the binding capacity of HIF-1 to its cofactors.
The results here suggest that Cu is likely involved in the cofactor-recruiting step of activation of HIF-1 through inhibition of FIH-1 activity. We have observed that FIH-1 gene silencing using RNA interference technique blocked the inhibitory effect of Cu deprivation by TEPA on hypoxia-induced luciferase reporter activity. To further confirm the possibility of Cu regulation of HIF-1 transcription activity through its action on FIH-1, we examined the effect of Cu deprivation on iron chelation-induced activation of HIF-1. It has been shown that FIH-1 activity is iron-dependent. In previous studies, it has been suggested that PHDs are iron-dependent so that iron chelation can inhibit the activity of PHDs, leading to an accumulation of HIF-1α (Wang and Semenza, 1993a) . However, recent studies have shown that iron chelation by DFO mainly inhibited FIH-1 activity (Hirsila et al., 2005) . (Smith and Martell, 1976) . The logK i values of Clioquinol are 15.8 for Cu(II) and 12.5 for Zn(II) (Cherny et al., 1999) . Apparently, K i value of TEPA-Cu is about 7 orders of magnitude higher than that of Clioquinol-Cu (K i TEPA-Cu / K i Clioquinol-Cu ). TEPA also has a remarkable higher selectivity for Cu(II) over Zn(II) (K i TEPA-Cu /K i TEPA-Zn : about 8 orders of magnitude) than Clioquinol (K i Clioquinol-Cu /K i Clioquinol-Zn : about 3 orders of magnitude). In addition, Zn has been shown to be a negative regulator of HIF-1 activation (Chun et al., 2000) .
Taken together, the discrepancy between TEPA and Clioquinol in the regulation of FIH-1 may be, at least in part, due to a remarkable difference in Cu selectivity and affinity.
It is important to note that TEPA is also able to bind other transition metals, such as Fe, Co and Ni, but with much lower affinity compared to Cu (Smith and Martell, 1976) . Iron Chelation inactivates PHD and causes HIF-1α accumulation and activation (Fig 6) . Although previous studies showed that exogenous Co and Ni treatment caused HIF-1 accumulation and activation (Maxwell and Salnikow, 2004) , there is yet no evidence that shows the effect of Co or Ni chelation on HIF-1 activation. The physiological concentrations of Co and Ni are very low and TEPA chealtion of Co or Ni is unlikely to affect HIF-1 activation.
This article has not been copyedited and formatted. The final version may differ from this version. In summary, we show here that Cu chelation suppresses hypoxia-induced HIF-1 transactivity and VEGF production in HepG2 cells. The requirement of Cu for HIF-1 activation and for the target gene expression provides a novel insight into the mechanism by which Cu manipulation affects various clinical practices, in particular, when angiogenesis is concerned. In this study, we have identified two action sites of Cu in HIF-1α activation (Fig 7) , cells were cultured in the presence or absence of TEPA (100 μM) for 24 h, and then CuSO 4 (100 μM) was added to the TEPA-treated cells and cells were then subjected to hypoxia (H) or normoxia (N) for 16 h. Co-immunoprecipitation was performed using a HIF-1α specific antibody in the whole cell lysates. The immunoprecipitants were resolved by SDS-PAGE and p300 was immunoblotted. The lysates were also subjected to Western blot, HIF-1α was probed for loading control. Immunoblot is a representative from three separate experiments with consistent results.
(B) Co-immunoprecipitation of HIF-1α by anti-p300. . N, normoxia control; H, hypoxia control;
TEPA-H, hypoxia after TEPA treatment; TEPA-Cu-H, hypoxia after addition of CuSO 4 (100 μM)
to the TEPA treated cells. Procedures were as the same as described in Fig. 3 . 
